These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33229108)

  • 1. Understanding immunosenescence and its impact on vaccination of older adults.
    Allen JC; Toapanta FR; Chen W; Tennant SM
    Vaccine; 2020 Dec; 38(52):8264-8272. PubMed ID: 33229108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly.
    Pereira B; Xu XN; Akbar AN
    Front Immunol; 2020; 11():583019. PubMed ID: 33178213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosenescence and human vaccine immune responses.
    Crooke SN; Ovsyannikova IG; Poland GA; Kennedy RB
    Immun Ageing; 2019; 16():25. PubMed ID: 31528180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells.
    Aiello A; Ligotti ME; Garnica M; Accardi G; Calabrò A; Pojero F; Arasanz H; Bocanegra A; Blanco E; Chocarro L; Echaide M; Fernandez-Rubio L; Ramos P; Piñeiro-Hermida S; Kochan G; Zareian N; Farzaneh F; Escors D; Caruso C; Candore G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosenescence and vaccine failure in the elderly.
    Grubeck-Loebenstein B; Della Bella S; Iorio AM; Michel JP; Pawelec G; Solana R
    Aging Clin Exp Res; 2009 Jun; 21(3):201-9. PubMed ID: 19571643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related decline in vaccination efficacy: The potential role of myeloid derived suppressor cells.].
    Perfilyeva YV; Karalnik BV; Ostapchuk YO; Kali A; Tleulieva RT; Abdolla N; Krasnoshtanov VK; Belyaev NN
    Adv Gerontol; 2020; 33(4):785-795. PubMed ID: 33342113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity.
    Oh SJ; Lee JK; Shin OS
    Immune Netw; 2019 Dec; 19(6):e37. PubMed ID: 31921467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving immunogenicity and effectiveness of influenza vaccine in older adults.
    Cao W; Kim JH; Chirkova T; Reber AJ; Biber R; Shay DK; Sambhara S
    Expert Rev Vaccines; 2011 Nov; 10(11):1529-37. PubMed ID: 22043953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses.
    Crooke SN; Ovsyannikova IG; Poland GA; Kennedy RB
    Exp Gerontol; 2019 Sep; 124():110632. PubMed ID: 31201918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related decline in immunity: implications for vaccine responsiveness.
    Kumar R; Burns EA
    Expert Rev Vaccines; 2008 May; 7(4):467-79. PubMed ID: 18444893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations in responses to vaccines in older people].
    Autran B
    Rev Mal Respir; 2019 Nov; 36(9):1047-1056. PubMed ID: 31522947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of immune responses to vaccines in elderly persons.
    Weinberger B; Herndler-Brandstetter D; Schwanninger A; Weiskopf D; Grubeck-Loebenstein B
    Clin Infect Dis; 2008 Apr; 46(7):1078-84. PubMed ID: 18444828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescence and influenza vaccine efficacy.
    Sambhara S; McElhaney JE
    Curr Top Microbiol Immunol; 2009; 333():413-29. PubMed ID: 19768417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosenescence: Implications for response to infection and vaccination in older people.
    Pera A; Campos C; López N; Hassouneh F; Alonso C; Tarazona R; Solana R
    Maturitas; 2015 Sep; 82(1):50-5. PubMed ID: 26044074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells.
    Garnica M; Aiello A; Ligotti ME; Accardi G; Arasanz H; Bocanegra A; Blanco E; Calabrò A; Chocarro L; Echaide M; Kochan G; Fernandez-Rubio L; Ramos P; Pojero F; Zareian N; Piñeiro-Hermida S; Farzaneh F; Candore G; Caruso C; Escors D
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
    Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
    PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.
    van den Berg SPH; Wong A; Hendriks M; Jacobi RHJ; van Baarle D; van Beek J
    Front Immunol; 2018; 9():82. PubMed ID: 29434600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines.
    McElhaney JE; Kuchel GA; Zhou X; Swain SL; Haynes L
    Front Immunol; 2016; 7():41. PubMed ID: 26941738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosenescence: what does it mean to health outcomes in older adults?
    McElhaney JE; Effros RB
    Curr Opin Immunol; 2009 Aug; 21(4):418-24. PubMed ID: 19570667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.